Tert-Butylhydroquinone Protects Liver Against Ischemia/Reperfusion Injury in Rats Through Nrf2-Activating Anti-Oxidative Activity.

Abstract:

BACKGROUND:Hepatic ischemia/reperfusion (I/R) injury is a serious complication that occurs in surgical operations such as hepatectomy and liver transplantation. NF-E2-related factor 2 (Nrf2) is a transcription factor that has been proven against inflammatory and oxidative injury. Tert-butylhydroquinone (tBHQ), a widely used Nrf2 activator, is a common food preservative. In this study, we attempt to investigate the potential protective role of tBHQ in hepatic I/R injury. METHODS:Twenty adult male rats were randomly divided into four groups: (1) sham+vehicle group; (2) I/R+vehicle group; (3) sham+tBHQ group; and (4) I/R+tBHQ group. The vehicle or tBHQ was divided into three injections at intervals of 12 hours in a model of hepatic I/R injury. Fluorescence quantitative polymerase chain reaction and Western blot analysis were used to examine Nrf2 mRNA and protein expression. The concentrations of malondialdehyde and superoxide dismutase activity were accessed, respectively. RESULTS:Compared with the sham+vehicle group, Nrf2 expression, malondialdehyde, content and serum alanine aminotransferase were significantly increased in the I/R+vehicle group, whereas superoxide dismutase activity was significantly decreased. However, in the I/R+tBHQ group, tBHQ ameliorated tissue damage; promoted glutathione-S-transferase, quinine oxidoreductase 1, and glutamate cysteine ligase inductions; and regained redox homeostasis in comparison with the I/R+vehicle group. Furthermore, the present study indicated that preconditioning with tBHQ suppressed the I/R-induced increase in the apoptotic protein levels of caspase-3, as well as the I/R-induced decrease in the levels of anti-apoptotic protein bcl-2. CONCLUSIONS:t-BHQ exerted potent anti-inflammatory effects in I/R-induced liver injury, and tBHQ would be a new effectively therapeutic measure for preventing hepatic I/R injury during liver surgery.

journal_name

Transplant Proc

authors

Zeng XP,Li XJ,Zhang QY,Liu QW,Li L,Xiong Y,He CX,Wang YF,Ye QF

doi

10.1016/j.transproceed.2016.12.008

subject

Has Abstract

pub_date

2017-03-01 00:00:00

pages

366-372

issue

2

eissn

0041-1345

issn

1873-2623

pii

S0041-1345(16)30950-2

journal_volume

49

pub_type

杂志文章
  • Modified liver-free multivisceral transplantation for a metastatic small bowel neuroendocrine tumor: a case report.

    abstract::Neuroendocrine tumors originating from the small bowel frequently metastasize to the lymph nodes and/or liver. Although surgical extirpation of the primary tumor and locoregional metastases epitomizes the management of patients with such tumors, this is not always possible with conventional surgical techniques. Nonres...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2015.01.007

    authors: Frilling A,Giele H,Vrakas G,Reddy S,Macedo R,Al-Nahhas A,Wasan H,Clift AK,Gondolesi GE,Vianna RM,Friend P,Vaidya A

    更新日期:2015-04-01 00:00:00

  • Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.

    abstract:PURPOSE:The assessment of glomerular filtration rate (GFR) is the most commonly used test of renal function. Cystatin-C, a cysteine protease inhibitor, which can be measured by light-scattering immunoassay, possesses many of the attributes required of the ideal GFR marker. Conversely, many endogenous markers that are w...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2004.06.009

    authors: Visvardis G,Griveas I,Zilidou R,Papadopoulou D,Mitsopoulos E,Kyriklidou P,Manou E,Ginikopoulou E,Meimaridou D,Pavlitou A,Sakellariou G

    更新日期:2004-07-01 00:00:00

  • Importance of technical aspects in the beginnings of a pancreas transplantation program.

    abstract::Pancreas and kidney transplantation is the treatment of choice for patients with type 1 diabetes mellitus and terminal renal insufficiency. Herein we have presented a series of 35 patients transplanted between 2002 and 2009 including periods before and after 2007 divided based on introduction of some technical aspects...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2009.12.001

    authors: Moya Herraiz A,Merino Torres JF,Sánchez Plumed J,Montalvá Orón E,Pareja Ibars E,López Andújar R,San Juan Rodríguez F,De Juan Burgueño M,Torres-Quevedo R,Argente Pla M,Sosa Quesada Y,Mir Pallardó J

    更新日期:2010-01-01 00:00:00

  • Risks of Living Donor Liver Transplantation Using Small-For-Size Grafts.

    abstract:BACKGROUND:In living donor liver transplantation (LDLT), a graft-to-recipient weight ratio (GRWR) of under 0.8 is recognized as the critical graft size. Our aim was to compare the survival rates of recipients with small-for-size grafts (SFSG: GRWR <0.8), normal-sized grafts (NSG), and large-for-size grafts (LFSG: GRWR ...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2020.01.136

    authors: Miyagi S,Shono Y,Tokodai K,Nakanishi W,Nishimura R,Fujio A,Sasaki K,Miyazaki Y,Kakizaki Y,Sasajima H,Kamei T,Unno M

    更新日期:2020-01-01 00:00:00

  • Impact of homocysteinemia on long-term renal transplant survival.

    abstract:AIM:We prospectively followed a cohort of 202 renal transplant recipients for 5 years to examine the impact of fasting homocysteinemia on long-term patient and renal allograft survival. METHODS:Cox proportional hazards regression analysis was used to identify independent predictors of all-cause mortality and graft los...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2005.05.041

    authors: Fonseca I,Martins L,Queirós J,Mendonça D,Dias L,Sarmento AM,Henriques AC,Cabrita A

    更新日期:2005-07-01 00:00:00

  • Hemophagocytic syndrome after living-related liver transplantation.

    abstract::Hemophagocytic syndrome (HPS) is a life-threatening hematological disorder in immunocompromised patients. Although the number of patients with HPS following liver transplantation is scarce the outcome is usually fatal. We report a patient who developed HPS following living-related liver transplantation (LRLT) and was ...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/s0041-1345(03)00511-6

    authors: Karasu Z,Kilic M,Cagirgan S,Lebe E,Yilmaz F,Demirbas T,Tokat Y

    更新日期:2003-06-01 00:00:00

  • Metabolic profile and cardiovascular risk in a population of renal transplant recipients.

    abstract:INTRODUCTION:Cardiovascular disease is more common in renal transplant recipients (RTRs) than in the general population, and is the major cause of both graft loss and patient death in RTRs. OBJECTIVES:This study aimed to characterize the cardiovascular risk factors, calculate the 7-year risk for major adverse cardiac ...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2015.03.031

    authors: Gonçalves M,Vieira P,Resende L,Durães J,Rosa N,Teixeira JA,Silva G

    更新日期:2015-05-01 00:00:00

  • Effect of Different Rituximab Doses on B Cell Count, Anti-A/B Antibody Titer, Graft Function, and Infectious Complications in ABO-Incompatible Renal Transplantation: A Prospective Study.

    abstract:BACKGROUND:ABO-incompatible kidney transplantation (ABOiKT) has been accepted as a viable and cost-effective modality with outcomes comparable to ABO-compatible transplants, but there is a concern regarding higher infectious complications in ABOiKT because of the heightened immunosuppression. The desensitization protoc...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2020.10.008

    authors: Thukral S,Shinde N,Ray DS

    更新日期:2020-12-02 00:00:00

  • Fibromyalgia and its clinical relevance in renal transplant recipients.

    abstract:OBJECTIVE:Recent evidence suggests that fibromyalgia syndrome (FS) is associated with inflammation and endothelial dysfunction. Our aim was to determine the prevalence of FS in renal transplant recipients and to identify possible links between FS and clinical and laboratory parameters. METHODS:Ninety-nine kidney trans...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2015.01.026

    authors: Erkmen Uyar M,Sezer S,Bal Z,Guliyev O,Tutal E,Genctoy G,Kulah E,Ozdemir Acar N,Haberal M

    更新日期:2015-05-01 00:00:00

  • Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts.

    abstract::Alpha-1 antitrypsin (AAT) is a serine protease inhibitor able to prevent diabetes onset in nonobese diabetic (NOD) mice and to prolong islet allograft survival in a nonautoimmune murine model. In this study, we explored the effect of chronic administration of human AAT (hAAT) on allogeneic (C57BL/6) islet graft surviv...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2008.02.010

    authors: Pileggi A,Molano RD,Song S,Zahr E,SanJose S,Villate S,Wasserfall C,Ricordi C,Atkinson MA,Inverardi L

    更新日期:2008-03-01 00:00:00

  • Clinical and experimental transplantation of isolated organ or tissue cells indications problems from the Polish perspective.

    abstract::Clinical cell transplantation remains as a clinical experiment. Morphologically intact and functional cells transplanted into their tissue of origin undergo rapid disintegration by attacking granulocytes and macrophages, leading to the so-called early graft dysfunction. When transplanted to sites remote from their ori...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/s0041-1345(03)00779-6

    authors: Olszewski WL

    更新日期:2003-09-01 00:00:00

  • Renal transplantation in Warsaw: a registry report.

    abstract::In a country undergoing socioeconomic transformation, with all the attendant financial difficulties, it is rather difficult to obtain very good results in this expensive and advanced method of therapy. However, in spite of such difficulties, the results obtained are equal to the European standards, with 85% and 65% on...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:

    authors: Lao M,Rowiński W,Wałaszewski J,Szmidt J

    更新日期:1996-12-01 00:00:00

  • Triple therapy using direct-acting agents for recurrent hepatitis C after liver transplantation: a single-center experience.

    abstract:BACKGROUND:Hepatitis C viral graft reinfection is almost a universal event after liver transplantation with consequent disease progression. METHODS:We applied triple therapy (n = 21) with the use of telaprevir (TVR; n = 12) or simeprevir (SVR; n = 9). RESULTS:TVR was given at the dose 1,500 mg daily (n = 11) with red...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2014.10.058

    authors: Ikegami T,Yoshizumi T,Soejima Y,Harimoto N,Itoh S,Takeishi K,Uchiyama H,Kawanaka H,Yamashita YI,Tsujita E,Harada N,Oki E,Saeki H,Kimura Y,Shirabe K,Maehara Y

    更新日期:2015-04-01 00:00:00

  • One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.

    abstract::The results from previous trials suggested that tacrolimus-based treatment in kidney transplantation was associated with a significantly lower incidence of acute rejection, and that cyclosporine microemulsion (CsA-Me)-treated patients converted to tacrolimus had numerically better 6-year graft survival than those rema...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2005.11.081

    authors: Chamienia A,Biedunkiewicz B,Król E,Debska-Slizień A,Rutkowski B

    更新日期:2006-01-01 00:00:00

  • One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.

    abstract::An account is given of the 6- to 12-month survival, and causes of failure in 110 consecutive patients who underwent primary liver transplantation under treatment from the outset with FK 506 and steroids. The patient survival is 92.7%, and the first graft survival is 87.3%. At a very high frequency, the patients achiev...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:

    authors: Todo S,Fung JJ,Tzakis A,Demetris AJ,Jain A,Alessiani M,Takaya S,Day R,Gordon R,Starzl TE

    更新日期:1991-02-01 00:00:00

  • Pregnancy outcomes among female recipients after liver transplantation: further experience.

    abstract:INTRODUCTION:Liver transplantations give female recipients an ability to carry pregnancies successfully. However, solid organ transplantations exacerbate the pregnancy including maternal and neonatal outcomes. The aim of our study was to evaluate and identify the obstetric outcomes in women with a prior liver transplan...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2011.08.070

    authors: Jabiry-Zieniewicz Z,Szpotanska-Sikorska M,Pietrzak B,Kociszewska-Najman B,Foroncewicz B,Mucha K,Zieniewicz K,Krawczyk M,Wielgos M

    更新日期:2011-10-01 00:00:00

  • Successful Re-resection for Locally Recurrent Retroperitoneal Liposarcoma at Four Years After Ex Vivo Tumor Resection and Autotransplantation of the Liver: A Case Report.

    abstract::Surgical resection should be considered for isolated locally recurrent retroperitoneal liposarcomas. We experienced a case of successful re-resection for locally recurrent retroperitoneal liposarcomas 4 years after ex vivo tumor resection and autotransplantation of the liver. A 75-year-old man was admitted to our hosp...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2016.01.026

    authors: Kobayashi T,Miura K,Ishikawa H,Soma D,Zhang Z,Yuza K,Hirose Y,Takizawa K,Nagahashi M,Sakata J,Kameyama H,Kosugi S,Wakai T

    更新日期:2016-05-01 00:00:00

  • Basiliximab: efficacy and tolerability in adults and children.

    abstract:UNLABELLED:An open, single arm, prospective clinical trial to assess the efficacy and safety of basiliximab (Simulect) combined with cyclosporine microemulsion (Neoral), steroids, and azathioprine was performed in four centers in Chile, two adult and two pediatric. The 23 patients who were enrolled were followed for 12...

    journal_title:Transplantation proceedings

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.transproceed.2003.09.098

    authors: Mocarquer A,Pinto V,Buckel E,Lagos E,Pefaur J,Ramirez K,Morales J,Rosatti P,Elberg A,Simulect Multicenter Study Group of Chile.

    更新日期:2003-11-01 00:00:00

  • Outcome of Living Donor Transplant Kidneys With Multiple Arteries.

    abstract:BACKGROUND:Living donor transplantation (LDT) using kidneys with multiple arteries (MA) has previously been reported to be associated with increased complications and poorer outcomes in recipients. The objective of this study was to investigate outcomes of LDT with MA at the National University Hospital of Singapore, a...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2015.12.104

    authors: Lim YM,Han X,Raman L,Ng TK,Goh TH,Vathsala A,Tiong HY

    更新日期:2016-04-01 00:00:00

  • Outcome of renal transplantation in patients with type 2 diabetic nephropathy: a single-center experience.

    abstract:BACKGROUND:Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on E...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2014.12.047

    authors: Noguchi H,Kitada H,Kaku K,Kurihara K,Kawanami S,Tsuchimoto A,Masutani K,Nakamura U,Tanaka M

    更新日期:2015-04-01 00:00:00

  • The proteasome inhibitor bortezomib inhibits intimal hyperplasia of autologous vein grafting in rat model.

    abstract:OBJECTIVE:Increasing evidence indicates that inflammation plays an important role in intimal hyperplasia (IH) induced by autologous vein grafts. The proteasome inhibitor bortezomib shows anti-inflammatory effects, so we used an autologous vein transplantation model to test whether bortezomib inhibits neointimal formati...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2008.01.063

    authors: He XP,Li XX,Bi YW,Yue WM,Sun WY,Pang XY,Gu XH

    更新日期:2008-06-01 00:00:00

  • The clinical implication of inhibiting platelet activation on chronic renal allograft dysfunction: a prospective cohort study.

    abstract:INTRODUCTION:Clinically chronic renal allograft dysfunction (CRAD) manifests as a progressive elevation of serum creatinine (Cr) with an associated deterioration in proteinuria and decrease in glomerular filtration rate (GFR) following the first year after transplantation. Currently, how to delay or reverse CRAD and im...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2011.05.047

    authors: Zhang Y,Zong HT,Yang CC,Zhang XD

    更新日期:2011-09-01 00:00:00

  • First living related kidney transplantation results in excellent outcomes for small children.

    abstract:OBJECTIVE:The aim of this study was to evaluated the outcomes of living related kidney transplantation in small children. MATERIALS AND METHODS:Ten pediatric patients with body weights less than 10 kg received parental kidney transplants (five mothers and five fathers). An intra-abdominal approach was used in nine chi...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2005.06.095

    authors: Aikawa A,Arai K,Kawamura T,Sugiyama K,Muramatsu M,Itabashi Y,Ohara T,Motoyama O,Hasegawa A

    更新日期:2005-09-01 00:00:00

  • Experience with cyclosporine in the Canary Islands.

    abstract::Cyclosporine (CsA) is currently the basis of most immunosuppressive protocols after solid organ transplantation. The introduction of Neoral, a new microemulsion formulation of CsA, and more recently a range of adjunctive immunosuppressants have further enhanced short-term efficacy and tolerability of CsA-based immunos...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章,评审

    doi:10.1016/j.transproceed.2003.12.030

    authors: Hernández D

    更新日期:2004-03-01 00:00:00

  • Immunomonitoring of renal transplant recipients in the early posttransplant period by sequential analysis of chemokine and chemokine receptor gene expression in peripheral blood mononuclear cells.

    abstract:INTRODUCTION:We sought to determine whether sequential changes in chemokine ligand/receptor gene expression in the early posttransplant period of human renal allografts can be detected in peripheral blood mononuclear cells (PBMCs) and whether any such changes are predictive of clinical events. METHODS:Blood samples fr...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2004.12.097

    authors: Dalton RS,Webber JN,Pead P,Gibbs PJ,Sadek SA,Howell WM

    更新日期:2005-03-01 00:00:00

  • The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney.

    abstract:INTRODUCTION:NKG2D, an activating receptor, may trigger NK and CD8+ T cells. Ligands for NKG2D and major histocompability complex class I chain-related antigen (MIC) have been reported to be expressed in rejected human renal allografts. MIC-NKG2D engagement may induce natural killer (NK) cell activation providing T-cel...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2006.06.013

    authors: Feng L,Cheng F,Ye Z,Li S,He Y,Yao X,Tang Q,Li Y

    更新日期:2006-09-01 00:00:00

  • Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.

    abstract:UNLABELLED:We studied the inhibition of nuclear factor of activated T-cell (NFAT)-regulated gene expression (interleukin-2 [IL-2], interferon-gamma [IFN-gamma], granulocyte-macrophage colony-stimulating factor [GMCSF]) in cyclosporine (CsA)-treated de novo patients with and without lymphopenia due to FTY720. MATERIALS...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2008.01.067

    authors: Sommerer C,Morath C,Giese T,Meuer S,Zeier M

    更新日期:2008-06-01 00:00:00

  • Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group.

    abstract:BACKGROUND:Conversion to sirolimus (SRL)-based immunosuppression in renal transplant recipients is an alternative for chronic allograft dysfunction (CAD), cancer and viral infections. We sought to analyze the indications for and safety and efficacy of conversion to SRL among renal transplant patients. METHODS/MATERIAL...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2012.07.010

    authors: Gois PH,Rivelli GG,Pereira LM,Mazzali M

    更新日期:2012-10-01 00:00:00

  • A Case Report of the Resolution of Multiple Recalcitrant Verrucae in a Renal Transplant Recipient After a Mycophenolate Mofetil Dose Reduction.

    abstract::Renal transplant recipients are at an increased risk of developing verrucae due to chronic immunosuppression, and certain therapies may confer a greater risk. Herein, we describe a 51-year-old woman with a 10-year-old unrelated kidney transplant who developed numerous therapy-resistant verrucae while on mycophenolate ...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2016.11.030

    authors: Ash MM,Jolly PS

    更新日期:2017-01-01 00:00:00

  • Living related pancreas transplantation alone with enteric drainage in Japan: case report.

    abstract::In this study, we report a living donor partial pancreas transplantation using intraportal donor-specific leukocyte transfusion (DSLT). The recipient was a 38-year-old woman who had type I diabetes mellitus for 17 years. Hypoglycemia occurred 2 or 3 times per week. Her hemoglobin A1c level was 9.0%, and she required 7...

    journal_title:Transplantation proceedings

    pub_type: 杂志文章

    doi:10.1016/j.transproceed.2008.08.052

    authors: Sato Y,Nakatsuka H,Yamamoto S,Oya H,Kobayashi T,Watanabe T,Kokai H,Kenmochi T,Hatakeyama K

    更新日期:2008-10-01 00:00:00